HTN Meds Tied to Lower Mortality After Pancreatic Cancer Diagnosis
The use of ARBs and ACE inhibitors after a pancreatic cancer diagnosis is associated with a reduced mortality risk.
Stay updated with breaking news from Scottw Keith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The use of ARBs and ACE inhibitors after a pancreatic cancer diagnosis is associated with a reduced mortality risk.
The largest longitudinal study to date shows that common and inexpensive blood pressure medications may prolong survival for pancreatic cancer patients.
E-Mail PHILADELPHIA - Primary liver cancer is on the rise worldwide, largely due to an increase in hepatitis C infections and chronic liver disease. Liver cancer is also hard to treat - it kills 750,000 people a year worldwide, making it the second deadliest type of cancer behind lung cancer. Current treatments include a targeted radiation therapy delivered with the help of radiation-emitting glass beads. New research shows that this treatment can be augmented by infusing microbubbles - small gas bubbles surrounded by a lipid shell - into the liver, and popping those bubbles by ultrasound, ...